BioMed Central | Articles which cite: Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	GM-CSF/IL-3/IL-5 receptor common beta chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cells. Selleri S, Deola S, Pos Z, Jin P, Worschech A, Slezak SL, Rumio C, Panelli MC, Maric D, Stroncek DF, Wang E, Marincola FM J Transl Med 2008, 6:17 [PubMed Central] [PubMed] [Related articles]
2.	Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors. Worschech A, Kmieciak M, Knutson KL, Bear HD, Szalay AA, Wang E, Marincola FM, Manjili MH Cancer Res 2008 Apr 1, 68:2436-46 [PubMed Central] [PubMed] [Related articles]
3.	A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers". Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D, Coukos G, Dhodapkar M, Håkansson L, Janetzki S, Kleen TO, Kirkwood JM, Maccalli C, Maecker H, Maio M, Malyguine A, Masucci G, Palucka AK, Potter DM, Ribas A, Rivoltini L, Schendel D, Seliger B, Selvan S, Slingluff CL, Stroncek DF, Streicher H, Wu X, Zeskind B, Zhao Y, Zocca MB, Zwierzina H, Marincola FM J Transl Med 2008, 6:81 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 3 articles in BioMed Central

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]